BEAR Procedure for ACL Injury
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new procedure called Bridge-Enhanced ACL Restoration (BEAR) to heal torn ACLs (a key ligament in the knee) using an implant and the patient's blood. The researchers aim to determine how age affects recovery with this treatment by comparing outcomes between older and younger patients. They are also monitoring for safety issues, such as infections or the need for additional surgery. This trial may suit individuals who recently injured their ACL within the last 50 days and still have a small part attached to the bone. As an unphased trial, it offers a unique opportunity to contribute to groundbreaking research and potentially benefit from an innovative treatment.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but it excludes people using corticosteroids or undergoing chemotherapy.
What prior data suggests that the BEAR procedure is safe for ACL injury treatment?
Research has shown that the BEAR procedure for ACL injuries is generally well-tolerated. One study found that only 8.3% of patients required another surgery within a year, increasing to 11.5% by the final follow-up. Notably, no ACL tears occurred in the first year, and only 2.1% experienced a tear later. These findings suggest that the BEAR procedure may be safe, with few complications like re-injury. However, as with any medical procedure, risks such as infection or the need for additional surgery should be considered.12345
Why are researchers excited about this trial?
The Bridge-Enhanced ACL Restoration (BEAR) procedure is unique because it offers a new approach to repairing ACL injuries by using an absorbable implant as a scaffold. Most current treatments for ACL injuries involve grafting, where a piece of tendon is taken from another part of the body or a donor to reconstruct the ligament. Unlike these grafts, the BEAR technique encourages the body to heal the torn ACL itself by bridging the gap between the torn ends, potentially leading to a more natural recovery. Researchers are excited about this method because it could reduce the risk of complications associated with grafts and promote a more natural healing process.
What evidence suggests that the BEAR procedure is effective for ACL injuries?
Research shows that the Bridge-Enhanced ACL Restoration (BEAR) procedure, which participants in this trial will undergo, holds promise for treating ACL injuries. Studies have found that BEAR can achieve results similar to traditional ACL surgery, with some patients experiencing better hamstring strength two years post-procedure. Additionally, BEAR patients often sustain fewer injuries to the opposite ACL within two years after surgery. This method uses a special implant and the patient's blood to aid in more effective healing of the torn ligament. Evidence suggests that BEAR serves as a good alternative to traditional ACL repair methods.14567
Are You a Good Fit for This Trial?
The BEAR III Trial is for individuals who have recently (within 50 days) injured their ACL and still have at least 5% of the ligament attached to the tibia. It's not suitable for those with allergies to bovine products or gelatin, a BMI over 35, history of knee issues like infections or moderate osteoarthritis, prior knee surgery, tobacco use, or severe allergic reactions.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo the Bridge-Enhanced ACL Restoration (BEAR) procedure, where an implant is placed between the torn ends of the ACL to stimulate healing
Follow-up
Participants are monitored for safety and effectiveness, including knee stability and function, up to two years after surgery
What Are the Treatments Tested in This Trial?
Interventions
- Bridge-Enhanced ACL Restoration (BEAR)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Miach Orthopaedics
Lead Sponsor